N-(3-bromo-6-phenylimidazo[1,2-a]pyrazin-8-yl)acetamide;3-bromo-6-phenyl-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]imidazo[1,2-a]pyrazin-8-amine;3-ethenyl-6-phenyl-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;1-[6-phenyl-8-(pyridin-3-ylmethylamino)imidazo[1,2-a]pyrazin-3-yl]ethanone;6-phenyl-N-(pyridin-3-ylmethyl)-3-thiophen-3-ylimidazo[1,2-a]pyrazin-8-amine
C95H75Br2F3N24O2S — CID 161227825
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(3-bromo-6-phenylimidazo[1,2-a]pyrazin-8-yl)acetamide;3-bromo-6-phenyl-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]imidazo[1,2-a]pyrazin-8-amine;3-ethenyl-6-phenyl-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;1-[6-phenyl-8-(pyridin-3-ylmethylamino)imidazo[1,2-a]pyrazin-3-yl]ethanone;6-phenyl-N-(pyridin-3-ylmethyl)-3-thiophen-3-ylimidazo[1,2-a]pyrazin-8-amine
N-(3-bromo-6-phenylimidazo[1,2-a]pyrazin-8-yl)acetamide;3-bromo-6-phenyl-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]imidazo[1,2-a]pyrazin-8-amine;3-ethenyl-6-phenyl-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;1-[6-phenyl-8-(pyridin-3-ylmethylamino)imidazo[1,2-a]pyrazin-3-yl]ethanone;6-phenyl-N-(pyridin-3-ylmethyl)-3-thiophen-3-ylimidazo[1,2-a]pyrazin-8-amine (PubChem CID 161227825) has the molecular formula C95H75Br2F3N24O2S and a molecular weight of 1833.68 g/mol. Its IUPAC name is N-(3-bromo-6-phenylimidazo[1,2-a]pyrazin-8-yl)acetamide;3-bromo-6-phenyl-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]imidazo[1,2-a]pyrazin-8-amine;3-ethenyl-6-phenyl-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;1-[6-phenyl-8-(pyridin-3-ylmethylamino)imidazo[1,2-a]pyrazin-3-yl]ethanone;6-phenyl-N-(pyridin-3-ylmethyl)-3-thiophen-3-ylimidazo[1,2-a]pyrazin-8-amine.
Molecular Properties
| Compound Name | N-(3-bromo-6-phenylimidazo[1,2-a]pyrazin-8-yl)acetamide;3-bromo-6-phenyl-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]imidazo[1,2-a]pyrazin-8-amine;3-ethenyl-6-phenyl-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;1-[6-phenyl-8-(pyridin-3-ylmethylamino)imidazo[1,2-a]pyrazin-3-yl]ethanone;6-phenyl-N-(pyridin-3-ylmethyl)-3-thiophen-3-ylimidazo[1,2-a]pyrazin-8-amine |
|---|---|
| PubChem CID | 161227825 |
| Molecular Formula | C95H75Br2F3N24O2S |
| Molecular Weight | 1833.68 g/mol |
| Exact Mass | 1830.45 |
| IUPAC Name | N-(3-bromo-6-phenylimidazo[1,2-a]pyrazin-8-yl)acetamide;3-bromo-6-phenyl-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]imidazo[1,2-a]pyrazin-8-amine;3-ethenyl-6-phenyl-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;1-[6-phenyl-8-(pyridin-3-ylmethylamino)imidazo[1,2-a]pyrazin-3-yl]ethanone;6-phenyl-N-(pyridin-3-ylmethyl)-3-thiophen-3-ylimidazo[1,2-a]pyrazin-8-amine |
| SMILES | C=Cc1cnc2c(NCc3cccnc3)nc(-c3ccccc3)cn12.CC(=O)Nc1nc(-c2ccccc2)cn2c(Br)cnc12.CC(=O)c1cnc2c(NCc3cccnc3)nc(-c3ccccc3)cn12.FC(F)(F)c1ccc(CNc2nc(-c3ccccc3)cn3c(Br)cnc23)cn1.c1ccc(-c2cn3c(-c4ccsc4)cnc3c(NCc3cccnc3)n2)cc1 |
| InChI | InChI=1S/C22H17N5S.C20H17N5O.C20H17N5.C19H13BrF3N5.C14H11BrN4O/c1-2-6-17(7-3-1)19-14-27-20(18-8-10-28-15-18)13-25-22(27)21(26-19)24-12-16-5-4-9-23-11-16;1-14(26)18-12-23-20-19(22-11-15-6-5-9-21-10-15)24-17(13-25(18)20)16-7-3-2-4-8-16;1-2-17-13-23-20-19(22-12-15-7-6-10-21-11-15)24-18(14-25(17)20)16-8-4-3-5-9-16;20-16-10-26-18-17(25-9-12-6-7-15(24-8-12)19(21,22)23)27-14(11-28(16)18)13-4-2-1-3-5-13;1-9(20)17-13-14-16-7-12(15)19(14)8-11(18-13)10-5-3-2-4-6-10/h1-11,13-15H,12H2,(H,24,26);2-10,12-13H,11H2,1H3,(H,22,24);2-11,13-14H,1,12H2,(H,22,24);1-8,10-11H,9H2,(H,25,27);2-8H,1H3,(H,17,18,20) |
| InChIKey | UYIXUMFFJUJRRK-UHFFFAOYSA-N |
| XLogP | 21.09 |
| TPSA | 296.80 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 127 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1833.68 |
| LogP ≤ 5 | 21.09 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 26 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161227825 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.